Fig. 4

Identification of key metabolic reprogramming-related genes. (A) The random survival forest analysis of metabolic reprogramming-related genes in neuroblastoma (NB). The variable relative importance of genes > 0.4 were identified as key genes in NB. (B-F) Kaplan-Meier survival analysis of NB patients with high- and low-expression of MRPL21, NHP2, RPL13, RPL18A, and RPL27A.